Los Angeles, Calif; Medford and North Grafton, Mass.; and Logan and Salt Lake City, Utah From the Keck School of Medicine, University of Southern California; Allergan, Inc.; Innovative Medical Device Solutions; the University of Utah School of Medicine; ARUP Laboratories; and the Cummings School of Veterinary Medicine, Tufts University.
Plast Reconstr Surg. 2014 Nov;134(5):700e-704e. doi: 10.1097/PRS.0000000000000697.
This study was designed to evaluate the SERI Surgical Scaffold, a silk-derived bioresorbable scaffold, in an ovine model of two-stage breast reconstruction. Sheep were implanted bilaterally with either SERI or sham sutures during the stage 1 procedure. The SERI group underwent an exchange procedure for a breast implant at 3 months; animals in the sham group were killed at 3 months. The sham samples were significantly weaker than the SERI plus tissue samples by 3 months. At all endpoints, SERI plus tissue samples were greater than or equal to 150 percent of native ovine fascial strength. Histologic evaluation of SERI samples showed evidence of bioresorption through 12 months. SERI provided adequate soft-tissue support with progressive bioresorption. By 12 months, newly formed tissue had assumed the majority of load-bearing responsibility.
本研究旨在评估 SERI 外科支架,一种丝衍生的可生物吸收支架,在羊两阶段乳房重建模型中的应用。在第一阶段手术中,羊的双侧分别植入 SERI 或假缝合线。SERI 组在 3 个月时进行了乳房植入物的交换手术;假手术组动物在 3 个月时被处死。3 个月时,假样本的强度明显低于 SERI 加组织样本。在所有终点,SERI 加组织样本的强度均大于或等于 150%的天然羊筋膜强度。SERI 样本的组织学评估显示在 12 个月内有生物吸收的证据。SERI 通过逐渐生物吸收提供了足够的软组织支撑。到 12 个月时,新形成的组织已经承担了大部分承重责任。